Oxford University Hospitals, University of Oxford, Oxford, UK.
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Early-phase cell line study profiling molecular responses to kinase inhibitors; identifies potential vulnerabilities but lacks human efficacy data, animal validation, or clinical endpoints needed to guide practice.
Umbrella review synthesizing nine systematic reviews on ecological-collective-flourishing mechanisms; evidence for causality is weak, largely cross-sectional and qualitative, with no examination of reciprocal human-non-human effects.